Trial Profile
A study of perampanel in patients with drug-resistant focal epilepsy (DRFE)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 Feb 2016
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Partial epilepsies
- Focus Adverse reactions; Therapeutic Use
- 24 Feb 2016 New trial record